Abstract:Colorectal cancer (CRC) is considered the world's fourth most deadly cancer. Its metastasis is associated with poor prognosis and weakens the effects of treatment. However, the potential molecular mechanisms and key genes involved in CRC metastasis have remained to be comprehensively elucidated. The objective of the present study was to identify the key genes and molecular pathways underlying CRC metastasis. Differentially expressed genes (DEGs) between primary CRC tissues and metastatic CRC were identified by analyzing the GSE2509 dataset from the Gene Expression Omnibus database. Subsequently, the DEGs were subjected to Gene Ontology (GO) term and Kyoto Encyclopedia of Genes and Genome (KEGG) pathway enrichment analyses via the Database for Annotation, Visualization and Integrated Discovery (DAVID). Next, the top ten hub genes were identified in a protein-protein interaction (PPI) network. Sub-network and pathway enrichment analysis were respectively performed with the plugin MCODE and DAVID. Finally, reverse transcription-quantitative polymerase chain reaction assays were performed to corroborate the expression levels of the top five potential metastasis-associated genes in the clinical samples of CRC patients. A total of 7,384 DEGs were obtained, among which 3,949 were upregulated and 3,435 were downregulated. GO and KEGG enrichment analyses identified numerous possible biological processes and pathways that may have a role in the metastasis of CRC. The leading ten hub genes, recognized from the PPI, were epidermal growth factor receptor (EGFR), Has proto-oncogene GTPase (HRas), Wnt family member 5A (Wnt5a), serine/threonine kinase 1 (Akt1), cyclin-dependent kinase inhibitor 1A (CDKN1a), early growth response 1, Ras homolog family member A, cyclin D1 and Ras-related C3 botulinum toxin substrate 1. Sub-network analysis disclosed the most prominent three modules. Ultimately, EGFR, HRas and Akt1 were verified to be upregulated DEGs, while Wnt5a and CDKN1a were downregulated DEGs when compared with the primary controls. In conclusion, the present study revealed several key genes and relevant molecular mechanisms that may enhance the current understanding of CRC metastasis, making them significant potential foci for the discovery of further CRC treatments.

Translational Research of Metastatic Colorectal Cancer

Delineating the Underlying Molecular Mechanisms and Key Genes Involved in Metastasis of Colorectal Cancer Via Bioinformatics Analysis

[Translational Medicine of Colorectal Cancer].

[Exploration of Translational Medicine Research in Metastasis and Invasion of Malignant Tumors].

Advances in Epigenetic Biomarker Research in Colorectal Cancer.

Metabonomics of human colorectal cancer: new approaches for early diagnosis and biomarker discovery.

Recent Advances in Biomarkers for the Targeted Therapy of Metastatic Colorectal Cancer

Biological factors driving colorectal cancer metastasis

Research Progression in Markers Associated with Colorectal Liver Metastasis

[New progression of translational research on colorectal cancer].

Metastasis organotropism in colorectal cancer: advancing toward innovative therapies

Mechanisms Regulating Colorectal Cancer Cell Metastasis into Liver (Review).

The updates on metastatic mechanism and treatment of colorectal cancer

Identification and prognostic analysis of candidate biomarkers for lung metastasis in colorectal cancer

Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives

Unveiling the best predictive models for early‐onset metastatic cancer: Insights and innovations (Review)

Translational Medicine in Primary Liver Cancer

Research Progress of Translational Medicine Based on Tumor Molecular Biomarkers

MicroRNA Regulation Network in Colorectal Cancer Metastasis

Metastatic Colorectal Cancer: Perspectives on Long Non-Coding RNAs and Promising Therapeutics.

Tumor metastasis: moving new biological insights into the clinic